MedCity News September 9, 2025
Strive Health’s Series D funding was led by New Enterprise Associates, and included participation from CVS Health Ventures, CapitalG, Echo Health and several others.
Strive Health, a value-based kidney care company, has raised $550 million in Series D funding, the company announced on Tuesday. The financing is $300 million in equity funding and $250 million in debt financing.
Denver, Colorado-based Strive Health works with payers, health systems, primary care groups and nephrologists. The company provides at-home and virtual support for chronic kidney disease, end-stage kidney disease, dialysis and kidney transplant. It leverages technology and AI to identify what disease stage patients are in and what the best interventions are. It also connects the patients with a care team that includes...
Today's Sponsors
Today's Sponsor